Table 1.
Demographics, baseline, and laboratory characteristics of moderate to severe COVID-19 patients.
| All Patients n = 1035 |
Moderate COVID-19 n = 789 |
Severe COVID-19 n = 246 |
p | |
|---|---|---|---|---|
| Characteristics | ||||
| Age (years) | 69 (58–79) | 70 (58–81) | 66 (57.3–72) | <0.001 * |
| Gender male | 609 (58.8) | 433 (54.9) | 176 (71.5) | <0.001 * |
| Obesity | 281 (36.9) | 193 (35.0) | 88 (41.9) | 0.076 |
| Comorbidities | ||||
| Hypertension | 587 (56.7) | 453 (57.4) | 134 (54.5) | 0.416 |
| Diabetes mellitus | 275 (26.7) | 202 (25.6) | 73 (26.6) | 0.207 |
| CKD | 237 (23.2) | 199 (25.5) | 38 (15.8) | 0.002 * |
| Cardiovascular disease | 357 (34.5) | 291 (36.9) | 66 (26.8) | 0.004 * |
| Total autonomy | 796 (77.2) | 569 (72.4) | 227 (92.7) | <0.001 * |
| Respiratory disease | 203 (19.6) | 151 (19.1) | 52 (21.1) | 0.490 |
| Laboratory Findings | ||||
| CRP (mg/L) | 81 (39–142.3) | 68 (33–128) | 124 (76–192) | <0.001 * |
| Lymphocyte (×109/L) | 870 (630–1200) | 900 (640–1220) | 780 (590–1122) | 0.003 * |
| CLR | 97.0 (39.3–189.5) | 83.0 (33.3–173.5) | 163.9 (83.8–310) | <0.0001* |
| Outcome | ||||
| Hospital stay (days) | 10 (7–17.3) | 8 (6–12) | 24 (17–38) | <0.001 * |
| Intra-hospital mortality | 139 (13.6) | 82 (10.4) | 57 (24.1) | <0.001 * |
Data are all expressed in median (Q1–Q3) or n/N (%), where N is the total number of patients with available data. BMI = body mass index, CKD = chronic kidney disease, CRP = C-reactive protein, CLR = CRP/lymphocyte count ratio * p < 0.05.